Document is current
Any future updates will be listed below
-
Authors
Meng, Yanxiang https://orcid.org/0000-0001-7447-9788
Davies, Katherine A. https://orcid.org/0000-0002-4423-4664
Fitzgibbon, Cheree
Young, Samuel N.
Garnish, Sarah E.
Horne, Christopher R. https://orcid.org/0000-0003-1318-514X
Luo, Cindy
Garnier, Jean-Marc
Liang, Lung-Yu
Cowan, Angus D. https://orcid.org/0000-0002-9702-7319
Samson, Andre L. https://orcid.org/0000-0002-0637-2716
Lessene, Guillaume https://orcid.org/0000-0002-1193-8147
Sandow, Jarrod J. https://orcid.org/0000-0001-5684-8236
Czabotar, Peter E. https://orcid.org/0000-0002-2594-496X
Murphy, James M. https://orcid.org/0000-0003-0195-3949
-
Funding
Funding for this research was provided by:
University of Melbourne (Research Scholarship)
Department of Industry, Innovation and Science, Australian Government
Wendy Dowsett Scholarship
Department of Health | National Health and Medical Research Council (2002965, 1117089, 2002965, 1079700, 1172929, 9000653)
Anaxis Pharma Pty Ltd.
- License Information
-
More Information
Article History
Received: 29 June 2021
Accepted: 29 October 2021
First Online: 22 November 2021
Competing interests
: Y.M., K.A.D., C.F., S.N.Y., S.E.G., C.L., J.-M.G., L.-Y.L., A.D.C., A.L.S., G.L., P.E.C., and J.M.M. contribute, or have contributed, to a project developing necroptosis inhibitors in collaboration with Anaxis Pharma Pty Ltd. The remaining authors declare no competing interests.
